Sage Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 10 | -$2.68 | -$0.83 | -$1.65 |
| Q2 2024 | 6 | -$2.66 | -$0.82 | -$1.64 |
| Q3 2024 | 7 | -$2.50 | -$0.77 | -$1.54 |
| Q4 2024 | 16 | -$2.06 | -$1.01 | -$1.52 |
| Q1 2025 | 7 | -$1.53 | -$1.06 | -$1.30 |
| Q2 2025 | 3 | -$1.97 | -$0.61 | -$1.21 |
| Q3 2025 | 6 | -$1.85 | -$0.57 | -$1.14 |
| Q4 2025 | 5 | -$1.76 | -$0.54 | -$1.08 |
| Q1 2026 | 4 | -$1.69 | -$0.52 | -$1.04 |
| Q2 2026 | 3 | -$1.64 | -$0.51 | -$1.01 |
| Q3 2026 | 2 | -$1.56 | -$0.48 | -$0.96 |
| Q4 2026 | 2 | -$0.96 | -$0.30 | -$0.59 |
Sage Therapeutics, Inc. Earnings Date And Information
Sage Therapeutics, Inc. last posted its earnings results on Tuesday, October 29th, 2024. The company reported $-1.53 earnings per share for the quarter, missing analysts' consensus estimates of $-1.52 by $0.01. The company had revenue of 11.87 M for the quarter and had revenue of 86.46 M for the year. Sage Therapeutics, Inc. has generated $-9 earnings per share over the last year ($-9.05 diluted earnings per share) and currently has a price-to-earnings ratio of -1.08. Sage Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2025 based on prior year's report dates.
Sage Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/29/2024 | Q3 2024 | -$1.52 | -$1.53 | -0.01 | $10.80 M | $11.87 M |
| 07/31/2024 | Q2 2024 | -$1.68 | -$1.70 | -0.02 | $8.85 M | $8.65 M |
| 04/25/2024 | Q1 2024 | -$1.63 | -$1.80 | -0.17 | $7.90 M | |
| 02/14/2024 | Q4 2023 | -$1.18 | -$0.55 | 0.63 | $77.97 M | |
| 11/07/2023 | Q3 2023 | -$2.64 | -$3.37 | -0.73 | $4.63 M | $2.72 M |
| 08/07/2023 | Q2 2023 | -$2.53 | -$2.68 | -0.15 | $2.94 M | $2.47 M |
| 05/02/2023 | Q1 2023 | -$2.50 | -$2.32 | 0.18 | $3.29 M | |
| 02/16/2023 | Q4 2022 | -$2.37 | -$2.24 | 0.13 | $2.87 M | |
| 11/08/2022 | Q3 2022 | -$2.16 | -$2.17 | -0.01 | $1.64 M | $1.74 M |
| 08/02/2022 | Q2 2022 | -$2.16 | -$2.06 | 0.1 | $1.76 M | $1.50 M |
| 05/03/2022 | Q1 2022 | -$2.09 | -$2.03 | 0.06 | $1.58 M | |
| 02/24/2022 | Q4 2021 | -$2.16 | -$2.12 | 0.04 | $1.64 M | |
| 11/02/2021 | Q3 2021 | -$1.84 | -$2.21 | -0.37 | $1.96 M | $1.44 M |
| 08/03/2021 | Q2 2021 | -$1.69 | -$1.83 | -0.14 | $2.00 M | $1.64 M |
| 05/04/2021 | Q1 2021 | -$1.98 | -$1.64 | 0.34 | $1.58 M | |
| 02/24/2021 | Q4 2020 | -$2.17 | $18.71 | 20.88 | $1.11 B | |
| 11/05/2020 | Q3 2020 | -$2.30 | -$2.03 | 0.27 | $1.84 M | $1.64 M |
| 08/10/2020 | Q2 2020 | -$2.67 | -$2.63 | 0.04 | $877,192 | $1.09 M |
| 05/07/2020 | Q1 2020 | -$3.17 | -$2.44 | 0.73 | $2.29 M | |
| 02/27/2020 | Q4 2019 | -$3.62 | -$3.25 | 0.37 | $1.96 M |
Sage Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Sage Therapeutics, Inc.'s earnings date?
Sage Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 12th, 2025 based off last year's report dates.
-
How can I listen to Sage Therapeutics, Inc.'s earnings conference call?
The conference call for Sage Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Sage Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Sage Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Sage Therapeutics, Inc. generate each year?
Sage Therapeutics, Inc. (:SAGE) has a recorded annual revenue of $86.46 M.
-
How much profit does Sage Therapeutics, Inc. generate each year?
Sage Therapeutics, Inc. (:SAGE) has a recorded net income of $86.46 M. Sage Therapeutics, Inc. has generated $-9.05 earnings per share over the last four quarters.
-
What is Sage Therapeutics, Inc.'s price-to-earnings ratio?
Sage Therapeutics, Inc. (:SAGE) has a price-to-earnings ratio of -1.08 and price/earnings-to-growth ratio is -0.04.
